The Role of von Willebrand Factor Antigen in Predicting Survival of Patients with HBV-Related Cirrhosis

Figure 4

vWF-Ag allowing additional risk stratification on patients with liver cirrhosis during follow-up. (a) Continuous risk for transplant-free mortality (HR) calculated for vWF-Ag. (b) The cumulative probability of transplant-free mortality compared with a vWF-Ag cutoff at 1925 U/L; (c) The cumulative probability of transplant-free mortality compared with a MELD cutoff at 9.2 points; (d) VWF-Ag being able to increase the area under the curve (AUC) of MELD alone for prediction of transplant-free mortality on the patients with liver cirrhosis during follow-up.

(a)

(b)

(c)

(d)